Innovative Hematology, Inc. (IHI)

Indianapolis, Indiana 46260

1 studies enrolling now · 1 studies all time

What they study most

Concomitant VWD and Hemophilia, Von Willebrand Disease, Type 3

Studies at this site

• Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A — Recruiting now